Cardiac Implants LLC Information

Cardiac Implants LLC is a clinical-stage company specializing in the development of percutaneous medical devices for the treatment of structural heart disease. We are developing a percutaneous tricuspid and mitral valve annuloplasty device, as well as a mitral valve replacement device that utilizes a unique, non-annular fixation technology. Our percutaneous repair technologies under development use the body’s natural healing process to create a "neo-annulus"​ around either atrioventricular valve to enable safe, easy and effective annular reduction and maintenance using a low profile complete circumferential ring implant. We are currently investigating our percutaneous tricuspid annuloplasty repair device, called the DaVingi TR System, in a first-in-human safety and feasibility study at sites in Israel, the Czech Republic and Spain. We collaborate with leading surgeons, cardiologists, pathologists, engineers, and scientists around the globe for the purpose of improving patient outcomes and quality of life. Our headquarters is based in the U.S. and our main R&D and manufacturing faclities located in Israel and California. All our products under development are for investigational use only and not approved for clinical use in any jurisdiction, including the U.S.